Small-cap stock under ₹50 to be in focus on Monday. Details here

Sudarshan Pharma Industries allotted 90 lakh equity shares upon conversion of 9 lakh warrants by promoters Hemal Vasantrai Mehta and Sachin Vasantrai Mehta, infusing ₹11.46 crore at an issue price of ₹16.983 per share. Post-allotment, promoter and promoter group shareholding rose to 58.93%, with the company's paid-up capital increasing to ₹24.96 crore. The stock, which has gained 22% over the past month and hit a 52-week high of ₹36.95 in May 2026, will be in focus on Monday.